MKTXS

Raritan, United States Founded: 2006 • Age: 20 yrs
Provides evidence-based strategies for pharmaceutical companies in market access and lifecycle planning.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 4 Services tracked
Competitors 9 Brand Intelligence

About MKTXS

MKTXS is a company based in Raritan (United States) founded in 2006. It operates as a B2B. MKTXS offers products and services including Evidence Generation, Pricing Strategy, Stakeholder Engagement, and Lifecycle Planning. MKTXS operates in a competitive market with competitors including Indegene, IntegriChain, Clinigen, Zuellig Pharma and Fishawack, among others.

  • Headquarter Raritan, United States
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Mktxs 4Biopharm Solutions Llp
  • Date of Incorporation 22 Jun, 2022
  • Jurisdiction Vadodara, Gujarat, India
Operational Areas
Healthcare → Healthcare Education, Research & Associations Unlock Sub-Sector Unlock Segment
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of MKTXS

MKTXS offers a comprehensive portfolio of products and services, including Evidence Generation, Pricing Strategy, Stakeholder Engagement, and Lifecycle Planning.

Product name locked
Category locked
Primary

Evaluates clinical burden and efficacy for pharmaceutical products.

Product name locked
Category locked
Locked

Develops optimal pricing and reimbursement plans for new drugs.

Product name locked
Category locked
Locked

Facilitates interactions with payers and regulators for product access.

Product name locked
Category locked
Locked

Supports product development phases from assessment to market entry.

Funding Insights of MKTXS

Premium access

Detailed funding history for MKTXS

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by MKTXS

Investments
Premium access

Investment portfolio details for MKTXS

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - MKTXS

Premium access

Detailed financials for MKTXS

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Mktxs Comparisons

MKTXS Primary company
Description
Provides evidence-based strategies for pharmaceutical compan...
Location
Raritan, United States
Founded Year
2006
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for MKTXS

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of MKTXS

MKTXS operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Indegene, IntegriChain, Clinigen, Zuellig Pharma and Fishawack, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Suite solutions are provided for payers and healthcare providers.
Locked Locked Locked
Inventory, order and customer relationship management solution for life science suppliers.
Locked Locked Locked
Specialty medicines are supplied via clinical trials and access programs.
Locked Locked Locked
Healthcare access in Asia is enhanced by Zuellig Pharma.
Locked Locked Locked
Fully integrated cross-border services are delivered to global pharmaceutical organizations.
Locked Locked Locked
Precision medicine integration is facilitated through analytics and services.
Premium access

Detailed competitors of MKTXS

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Mktxs

Premium access

Complete news archive for MKTXS

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about MKTXS

MKTXS was founded in 2006.

MKTXS is headquartered in Raritan, United States. It is registered at Raritan, New Jersey, United States.

MKTXS is a boutique global consultancy that collaborates with life science companies to develop customized, evidence-based strategies for optimizing product value and enhancing patient access. They offer services like evidence generation, pricing strategies, stakeholder engagement, and secondary research. Operating from offices in the US, UK, and India, they serve pharmaceutical clients worldwide by evaluating clinical efficacy and generating value stories through innovative platforms.

MKTXS's top competitors include Indegene, Zuellig Pharma and IntegriChain.

MKTXS offers Evidence Generation, Pricing Strategy, Stakeholder Engagement, and Lifecycle Planning.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available